Barclays’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Hold
16,200
﹤0.01% 2656
2026
Q1
$1.05M Buy
+16,200
New +$1.14M ﹤0.01% 2734
2020
Q1
Sell
-14,900
Closed -$264K 6264
2019
Q4
$264K Sell
14,900
-3,300
-18% -$57.2K ﹤0.01% 4821
2019
Q3
$282K Sell
18,200
-2,100
-10% -$34.6K ﹤0.01% 4709
2019
Q2
$348K Buy
20,300
+13,100
+182% +$211K ﹤0.01% 4648
2019
Q1
$116K Buy
7,200
+3,200
+80% +$51.9K ﹤0.01% 5246
2018
Q4
$59K Buy
+4,000
New +$63.8K ﹤0.01% 5379
2018
Q2
Sell
-67,200
Closed -$1.32M 7075
2018
Q1
$1.32M Buy
67,200
+65,200
+3,260% +$1.26M ﹤0.01% 2897
2017
Q4
$41K Buy
+2,000
New +$36.8K ﹤0.01% 5869
2017
Q3
Sell
-700
Closed -$9K 6920
2017
Q2
$9K Buy
+700
New +$9.35K ﹤0.01% 6080
2015
Q1
Sell
-7,500
Closed -$68K 7143
2014
Q4
$68K Hold
7,500
﹤0.01% 5481
2014
Q3
$68K Hold
7,500
﹤0.01% 5626
2014
Q2
$68K Hold
7,500
﹤0.01% 5738
2014
Q1
$90K Sell
7,500
-32,500
-81% -$482K ﹤0.01% 5539
2013
Q4
$560K Buy
40,000
+21,600
+117% +$278K ﹤0.01% 3982
2013
Q3
$202K Buy
+18,400
New +$153K ﹤0.01% 5025

Other funds holding HALO

Barclays's HALO Position: Q2 2026 in Review

Barclays increased its Halozyme (HALO) stake by 58% in Q2 2026, buying an estimated $7.67M and bringing the position to 305,663 shares worth $23.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Barclays first reported a position in HALO in Q2 2013 and has held it in 53 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Barclays held 305,663 shares of Halozyme worth $23.9M as of Q2 2026.
  • Barclays bought 112,421 Halozyme shares in Q2 2026, an estimated $7.67M.
  • Halozyme made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1037 holding.
  • Barclays first reported a position in Halozyme in Q2 2013 and has held it in 53 quarters since.
  • 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.